To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the impact of late presentation and diagnosis of liver disease on the incidence of hepatocellular carcinoma.
No specific assessment has been made. We would expect general practitioners to use professional judgement in diagnosing liver disease and refer patients as appropriate.
Between 2015 and 2020, hepatitis C-related mortality from end stage liver disease and hepatocellular carcinoma has reduced by 20%. NHS England’s cancer programme is working with the hepatitis C elimination programme to deliver 11 community liver health check pilots. These pilots aim to support earlier detection and diagnosis of liver cancer by identifying and referring people with cirrhosis or advanced fibrosis into a liver surveillance pathway.